Who owns BIOMARIN PHARMACEUTICAL?
- CUSIP Number: 09061gak7
Tip: Access positions for across all investors
Analyze quarterly positions in Biomarin Pharmaceutical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biomarin Pharmaceutical stock
Who bought or sold BIOMARIN PHARMACEUTICAL this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| MacKay Shields | 76M | $75M | 0% | Mar 2024 |
|
| Lazard Asset Management | 51M | $53M | 0% | Dec 2023 |
|
| Wellesley Investment Advisors | 41M | $42B | -14% | Dec 2023 |
|
| Victory Capital Management | 18M | $18M | 28% | Mar 2024 |
|
| iA Global Asset Management | 16M | $16M | 11% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 14M | $14M | 0% | Mar 2024 |
|
| Thrivent Financial for Lutherans | 12M | $12M | 1% | Mar 2024 |
|
| Shenkman Capital Management | 11M | $11B | -5% | Mar 2024 |
|
| Morgan Stanley | 10M | $10M | 17% | Mar 2024 |
|
| Sonora Investment Management Group | 9.9M | $9.9M | -9% | Mar 2024 |
|
| Jpmorgan Chase & Co | 7.2M | $7.1M | 32% | Mar 2024 |
|
| Bank of America Corporation | 7.1M | $7.0M | 0% | Mar 2024 |
|
| Leucadia National Corporation | 5.4M | $5.3M | 921% | Mar 2024 |
|
| Franklin Resources | 5.1M | $5.1M | 100% | Mar 2024 |
|
| Wellington Management Company | 5.1M | $5.2M | 134% | Dec 2023 |
|
| Amundi | 5.0M | $5.0M | 0% | Mar 2024 |
|
| BlackRock | 4.8M | $4.7M | 20% | Mar 2024 |
|
| New York State Common Retirement Fund | 4.6M | $4.5M | 0% | Mar 2024 |
|
| Bank Of Montreal | 4.5M | $4.5M | 100% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 4.4M | $4.4M | 0% | Mar 2024 |
|
| SSI Investment Management | 4.2M | $4.4M | 100% | Dec 2023 |
|
| Kornitzer Capital Management | 3.0M | $3.0M | 50% | Mar 2024 |
|
| Pier 88 Investment Partners | 2.6M | $2.6M | 0% | Mar 2024 |
|
| Huntington Asset Advisors | 2.5M | $2.5M | 0% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 2.3M | $2.3M | -10% | Mar 2024 |
|
| Man Group | 2.2M | $2.1M | 0% | Mar 2024 |
|
| Loomis, Sayles and | 2.1M | $182M | 1% | Mar 2024 |
|
| Palisade Capital Management | 1.9M | $1.9M | 0% | Mar 2024 |
|
| Edmond De Rothschild Holding | 1.2M | $1.2M | 0% | Mar 2024 |
|
| Liberty Mutual Group Asset Management | 1.0M | $1.0M | 0% | Mar 2024 |
|
| Ofi Invest Asset Management | 1.0M | $1.9M | 100000% | Mar 2024 |
|
| Kohlberg Kravis Roberts & Co | 700k | $694k | 31% | Mar 2024 |
|
| Sei Investments | 653k | $644k | 0% | Mar 2024 |
|
| American Century Companies | 318k | $315k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 300k | $298k | 0% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 261k | $257k | 100% | Mar 2024 |
|
| KBC Group NV | 250k | $249k | 0% | Mar 2024 |
|
| Barclays | 236k | $234k | -32% | Mar 2024 |
|
| Zurcher Kantonalbank | 200k | $197k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 126k | $125k | 0% | Mar 2024 |
|
| Cetera Investment Advisers | 117k | $115k | 100% | Mar 2024 |
|
| D.A. Davidson & Co. | 110k | $109k | 0% | Mar 2024 |
|
| First Hawaiian Bank | 102k | $101k | 0% | Mar 2024 |
|
| Raab & Moskowitz Asset Management | 30k | $31k | 0% | Dec 2023 |
|
| Calamos Advisors | 16k | $16k | 0% | Mar 2024 |
|
| Brian McDonald | 15k | $15k | -46% | Mar 2024 |
|
| Aurum Wealth Management Group | 14k | $14k | 0% | Dec 2023 |
|
| Foresight Capital Management Advisors | 13k | $13k | 0% | Mar 2024 |
|
| Mason & Associates | 13k | $13k | 100% | Mar 2024 |
|
| Capital Investment Advisors | 11k | $11k | 0% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 10k | $9.9k | 0% | Mar 2024 |
|
| Davenport & Co | 10k | $994k | 9900% | Mar 2024 |
|
| Envestnet Asset Management | 10k | $9.9k | 100% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 7.0k | $6.9k | 75% | Mar 2024 |
|
Who sold out of Biomarin Pharmaceutical?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| La Banque Postale Asset Management SA | Dec 2023 | 3.1M | $3.2M |
| Banque Pictet & Cie Sa | Dec 2023 | 568k | $586k |
| Multi-Financial Securities | Sep 2023 | 61k | $60k |
| Financial Network Investment Corporation | Sep 2023 | 56k | $56k |
| Leisure Capital Management | Dec 2023 | 12k | $12k |